EQ Inc.
CYPXF
$0.758
-$0.1877-19.85%
| Weiss Ratings | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.04 | |||
| Price History | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -19.85% | |||
| 2-Year Total Return | -19.85% | |||
| 3-Year Total Return | -19.85% | |||
| 5-Year Total Return | 47.76% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.76 | |||
| 52-Week Low Price | $0.76 | |||
| 52-Week Low Price (Date) | Nov 29, 2024 | |||
| 52-Week High Price (Date) | Nov 29, 2024 | |||
| Valuation | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 49.09M | |||
| Enterprise Value | 49.74M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | 33.94% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 7.41 | |||
| Price/Book (Q) | -57.42 | |||
| Enterprise Value/Revenue (TTM) | 7.77 | |||
| Price | $0.76 | |||
| Enterprise Value/EBITDA (TTM) | -46.58 | |||
| Enterprise Value/EBIT | -45.15 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 69.55M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 1235 Bay Street Toronto, ON M5R 3K4 | |||
| Website | www.eqworks.com | |||
| Country | Canada | |||
| Year Founded | 1995 | |||
| Profitability | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -17.20% | |||
| Profit Margin | -48.17% | |||
| Management Effectiveness | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -16.08% | |||
| Return on Equity | -- | |||
| Income Statement | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 7.12M | |||
| Total Revenue (TTM) | 7.12M | |||
| Revenue Per Share | $0.10 | |||
| Gross Profit (TTM) | 825.90K | |||
| EBITDA (TTM) | -1.19M | |||
| EBIT (TTM) | -1.22M | |||
| Net Income (TTM) | -3.43M | |||
| Net Income Avl. to Common (TTM) | -3.43M | |||
| Total Revenue Growth (Q YOY) | -7.79% | |||
| Earnings Growth (Q YOY) | 2,001.44% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 2,000.00% | |||
| Balance Sheet | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 341.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 2.67M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -919.40K | |||
| Current Ratio (Q) | 0.773 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 3.27M | |||
| Total Current Liabilities (Q) | 3.45M | |||
| Total Debt (Q) | 1.02M | |||
| Total Liabilities (Q) | 4.19M | |||
| Total Common Equity (Q) | -919.40K | |||
| Cash Flow | CYPXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -435.90K | |||
| Cash from Financing (TTM) | 211.10K | |||
| Net Change in Cash (TTM) | 11.00K | |||
| Levered Free Cash Flow (TTM) | -553.50K | |||
| Cash from Operations (TTM) | 235.90K | |||
